HEMOCOVID-19: an international project evaluating microvascular and endothelial dysfunction in COVID-19 patients with diffuse optics

Turgut Durduran; Marco Pagliazzi; Lorenzo Cortese; Umut Karadeniz; Jaume Mesquida

doi:10.1117/12.2579560

5 March 2021 HEMOCOVID-19: an international project evaluating microvascular and endothelial dysfunction in COVID-19 patients with diffuse optics

Turgut Durduran, Marco Pagliazzi, Lorenzo Cortese, Umut Karadeniz, Jaume Mesquida

Author Affiliations +

Proceedings Volume 11626, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2021; 1162608 (2021) https://doi.org/10.1117/12.2579560
Event: SPIE BiOS, 2021, Online Only

Abstract

As coronavirus disease 2019 (COVID-19) has spread across the world, the surge in patients requiring ICU admission has been overwhelming.The rapid diagnosis and isolation, clinical management, and infection prevention are the main challenges associated with this pandemic. When the disease becomes critical, adequate management of acute respiratory failure and supporting the hemodynamics is key in order to minimize the negative impact on survival. However, many questions on prognosis and efficient clinical management remain unanswered. HEMOCOVID-19 uses near-infrared diffuse optical technologies to non-invasively evaluate endothelial and microvascular dysfunction to aid both the development of targeted therapies and also to personalize rescue therapies. HEMOCOVID-19 has eleven partners in four countries and is open for new members. I will present the project and the preliminary results. I will then briefly explain the vision for the longer-term.

Conference Presentation

Citation Download Citation

Turgut Durduran, Marco Pagliazzi, Lorenzo Cortese, Umut Karadeniz, and Jaume Mesquida "HEMOCOVID-19: an international project evaluating microvascular and endothelial dysfunction in COVID-19 patients with diffuse optics", Proc. SPIE 11626, Photonic Diagnosis, Monitoring, Prevention, and Treatment of Infections and Inflammatory Diseases 2021, 1162608 (5 March 2021); https://doi.org/10.1117/12.2579560

ACCESS THE FULL ARTICLE

INSTITUTIONAL
Select your institution to access the SPIE Digital Library.

SELECT YOUR INSTITUTION

PERSONAL
Sign in with your SPIE account to access your personal subscriptions or to use specific features such as save to my library, sign up for alerts, save searches, etc.

PERSONAL SIGN IN

No SPIE Account? Create one

PURCHASE THIS CONTENT

SUBSCRIBE TO DIGITAL LIBRARY

50 downloads per 1-year subscription

Members: $195

Non-members: $335 ADD TO CART

25 downloads per 1 - year subscription

Members: $145

Non-members: $250 ADD TO CART

PURCHASE SINGLE ARTICLE

Includes PDF, HTML & Video, when available